Year: 2021

Relief Therapeutics Takes First Step to Create an ADR Program in the United States by Filing a Form F-6 Registration Statement with the U.S. Securities and Exchange Commission

GENEVA, SWITZERLAND / ACCESSWIRE / November 3, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF) ("Relief"), announced today that it has...

Digital Diagnostics Extends Appreciation to CMS for Improving Access to Innovative, Validated Healthcare AI Designed to Eliminate Disparities and Drive Equity

CORALVILLE, Iowa, Nov. 3, 2021 /PRNewswire/ -- Digital Diagnostics commends the Centers for Medicare & Medicaid Services (CMS) for recognizing...

error: Content is protected !!